At 2022 Russell indexes annual reconstitution, following notable health care stocks will be added to and deleted from the Russell 3000 Index. Notable additions: Clover Health Investments (CLOV), Aurinia Pharmaceuticals (AUPH), Nano-X Imaging (
NNOX), ADMA Biologics (ADMA), Hims & Hers Health (HIMS), Ginkgo Bioworks (DNA), Xeris Biopharma (XERS), CTI BioPharma (CTIC), Quantum-Si (QSI), Sema4 Holdings (SMFR). Notable deletions: Asensus Surgical (ASXC), Clovis Oncology (CLVS), Mind Medicine (MNMD), Athersys (ATHX), Tonix Pharmaceuticals (TNXP), iBio (NYSE:IBIO), Atossa Therapeutics (NASDAQ:ATOS), Viking Therapeutics (NASDAQ:VKTX), Verastem (NASDAQ:VSTM), Omeros (NASDAQ:OMER). The changes are effective on June 24 after market close.
For further details see:
Clover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletions